Mechanistically, we found that JAK2 and STAT6 were suppressed to a greater degree during monocyte-to-macrophage differentiation in patients with SLE compared with controls, especially among patients with atherosclerosis. The gene discussed is JAK2; the disease is systemic lupus erythematosus.